Target Name: MIR3670-2
NCBI ID: G100846994
Review Report on MIR3670-2 Target / Biomarker Content of Review Report on MIR3670-2 Target / Biomarker
MIR3670-2
Other Name(s): hsa-mir-3670-2 | microRNA 3670-2 | hsa-miR-3670 | MicroRNA 3670-2

MIR3670-2: A Potential Drug Target and Biomarker

MIR3670-2, a protein encoded by the human gene MIR3670, is a potential drug target and biomarker that has been shown to play a critical role in various cellular processes. MIR3670-2 has been identified as a potential drug target due to its unique structure and its involvement in multiple cellular processes, including cell signaling, cell adhesion, and chromatin regulation.

The MIR3670 gene is located on chromosome 16q24 and encodes a protein of approximately 230 amino acids. The protein has a unique feature, known as a micro-tubule-associated protein (MTAP) domain, which is a common protein found in microtubules of eukaryotic cells. The MTAP domain is known for its ability to interact with microtubules and disrupt their stability, leading to the regulation of various cellular processes.

One of the most significant functions of MIR3670-2 is its role in cell signaling. MIR3670-2 has been shown to play a critical role in the regulation of T-cell signaling, which is a crucial process for the immune system. MIR3670-2 has been shown to interact with the protein tyrosine kinase (TK) and prevent its phosphorylation, which is a key event in T-cell signaling. This interaction between MIR3670-2 and TK highlights the protein's potential as a drug target for T-cell disorders.

MIR3670-2 has also been shown to play a critical role in cell adhesion. Adhesion is a process by which cells stick together to form tissues and organs. MIR3670-2 has been shown to be involved in the regulation of cell adhesion, as it has been shown to interact with the protein cadherin. This interaction between MIR3670-2 and cadherin highlights the protein's potential as a drug target for cell adhesion disorders.

In addition to its role in cell signaling and adhesion, MIR3670-2 has also been shown to play a critical role in chromatin regulation. Chromatin is the complex of DNA, RNA, and proteins that make up the chromosomes. MIR3670-2 has been shown to be involved in the regulation of chromatin structure and stability, which is crucial for the proper functioning of the chromosome.

MIR3670-2 has been shown to have a direct impact on the chromatin structure and stability by interacting with the protein histone H3. Histone H3 is a key protein that makes up the nucleosome, which is the basic unit of chromatin. MIR3670-2 has been shown to interact with histone H3 and prevent its phosphorylation, which is a key event in chromatin regulation. This interaction between MIR3670-2 and histone H3 highlights the protein's potential as a drug target for chromatin regulation disorders.

In conclusion, MIR3670-2 is a protein with a unique structure and a critical role in various cellular processes. Its potential as a drug target due to its involvement in cell signaling, cell adhesion, and chromatin regulation makes it an attractive target for future research. Further studies are needed to fully understand the functions of MIR3670-2 and its potential as a drug.

Protein Name: MicroRNA 3670-2

The "MIR3670-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3670-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945